In this article, Terrance Holbrook, MasterControl, explains how working closely with suppliers and contractors, coupled with adopting robust automation tools, can yield greater visibility into partners’ quality related processes and, ultimately, lead to higher quality in pharmaceutical manufacturers’ outsourced activities and purchased materials.
The pharmaceutical outsourcing of manufacturing, quality and development functions is expanding. It has become common for pharmaceutical manufacturers to use many suppliers, contract manufacturing organisations (CMOs), contract research organisations (CROs) and contract development and manufacturing organisations (CDMOs). As the pharmaceutical supply chain grows longer, so too do suppliers’ own networks.
Nice Insight’s latest annual survey of pharmaceutical and biopharma professionals indicates that companies have dramatically increased year-on-year spending on outsourcing in the last 4 years and, for the fourth consecutive year, spending on outsourcing is expected to increase during the next 5 years.1
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.